EvolutionaryScale

EvolutionaryScale develops AI models that generate novel proteins for scientific research. Their flagship model, ESM3, creates proteins for drug discovery and materials science, accelerating the design process and enabling breakthroughs in various fields. The company plans to monetize through partnerships, usage fees, and revenue sharing.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $142M

Date: 25-Jun-2024

Investors: Nat Friedman, Daniel Gross, Lux Capital, Amazon, NVentures

Markets: Biotechnology, AI, Drug Discovery, Materials Science

HQ: New York, New York, United States

Founded: 2023

Website: https://www.evolutionaryscale.ai/

LinkedIn: https://www.linkedin.com/company/evolutionaryscale

Twitter:

Instagram: